Apontis Pharma AG
XETRA APPH.DE
Apontis Pharma AG Price to Book Ratio (P/B) on February 05, 2025: 2.94
Apontis Pharma AG Price to Book Ratio (P/B) is 2.94 on February 05, 2025, a 97.06% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Apontis Pharma AG 52-week high Price to Book Ratio (P/B) is 2.94 on February 05, 2025, which is 0.00% below the current Price to Book Ratio (P/B).
-
Apontis Pharma AG 52-week low Price to Book Ratio (P/B) is 1.55 on February 09, 2024, which is -47.32% below the current Price to Book Ratio (P/B).
-
Apontis Pharma AG average Price to Book Ratio (P/B) for the last 52 weeks is 2.27.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Don’t Miss A Beat
XETRA: APPH.DE
| CEO | Mr. Bruno Wohlschlegel |
| IPO Date | May 11, 2021 |
| Location | Germany |
| Headquarters | Alfred-Nobel-Str. 10 |
| Employees | 177 |
| Sector | Healthcare |
| Industries | |
Description
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
Key trends
Past 5 years
StockViz Staff
February 6, 2025
Any question? Send us an email